About: Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis. The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.52 (+8.21%)
CMMB NASDAQ Chemomab Therapeutics Ltd DRC
Chemomab Therapeutics Ltd DRC share price
CMMB price activity
Last Price
$1.520
Change (24hr)
0.12 USD (8.21%)
Volume
62.39K
Volume (4w avg)
-
Open
$1.46
Day Range
$1.39 - $1.60
Previous Close
$1.40
Last Trade
13 Nov, 7:27 pm GMT+0
Delayed
13 Nov, 7:27 pm GMT+0
CMMB price performance
Delayed
13 Nov, 7:27 pm GMT+0
CMMB details
CMMB Market Signals